Urological oncology.

The latest findings. State-of-the-art medicine.

The research area of urological oncology covers the entire spectrum of urological malignancies. It includes the Laboratory for Urological Oncology and the area of clinical research work. Experimental work on expressions of protein and nucleic acid is conducted at the laboratory; the clinical work includes scientifically evaluating the courses of diseases. Through the close cooperation of the two areas, the results determined in the laboratory can be directly related to those who are affected in the clinic: optimal preconditions for translational research.

In addition to the diagnostic and prognostic issues, the focus is on the identification of dysfunctions in the tumour cells; this can be used for a treatment with new medications (molecular targeted therapies). We also depict predictive tumour traits that can enable successful treatments in the affected patients. Scientific and technical employees support our clinical research groups so that those who work in the clinic have direct access to the experimental work.

Through close networking with the clinic, the research area receives a comprehensive tissue and body material bank. All of the customary histochemical, molecular and genetic methods are utilised. In addition, we are integrated into numerous research cooperations with international institutes, clinics and commercial cooperation partners. The available sample collectives allow instrument-based data collection within the scope of market introductions.

In the laboratory, newly developed examination techniques are already offered for patients of the clinic. These complex diagnoses include molecular and genetic examinations of the urine and blood within the scope of a university-based diagnosis of prostate and bladder cancer, as well as describing genetic patterns of the circulating tumour cells.